Pricing Log in Create free account

Jyong Biotech Ltd. (MENS) vs Protara Therapeutics, Inc. (TARA)

Jyong Biotech Ltd. and Protara Therapeutics, Inc. are both Biotechnology companies. Jyong Biotech Ltd. and Protara Therapeutics, Inc. are of similar size ($135.9M and $133.6M). Across the 5 metrics below, Jyong Biotech Ltd. leads on 3 and Protara Therapeutics, Inc. on 2.

Valuation

Metric MENS TARA Biotechnology median
P/E — n/m 10.60
P/S — n/m 9.40
P/B n/m 0.87 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA n/m 0.02 0.66
EV/Sales n/m n/m 9.02
Earnings yield — (58.70%) (32.88%)
Free cash flow yield — (47.40%) (23.13%)

Profitability

Metric MENS TARA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — (45.80%) (51.96%)
Return on assets — (42.05%) (46.06%)
Return on invested capital 0.00% (255.06%) 0.00%

Growth

Metric MENS TARA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (42.18%) 38.25% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MENS TARA Biotechnology median
Debt to equity (0.74) 0.00 0.00
Current ratio 0.45 10.97 4.97
Net debt to EBITDA (6.89) 2.38 1.01

Dividend

Metric MENS TARA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MENS TARA Biotechnology median
Market cap 133.62m 135.92m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack